USE OF PERAMPANEL IN THE TREATMENT OF EPILEPSY: A REVIEW OF LITERATURE AND A CASE REPORT

Despite a considerable advance made in epileptology, resistant epilepsies account for approximately 30 % of all forms of epilepsy particularly in patients with focal seizures. The most common structural cause of resistant epilepsies in children is focal cortical dysplasias that are varieties of abno...

Full description

Saved in:
Bibliographic Details
Main Authors: K. Yu. Mukhin, O. A. Pylaeva
Format: Article
Language:Russian
Published: ABV-press 2016-08-01
Series:Русский журнал детской неврологии
Subjects:
Online Access:https://rjdn.abvpress.ru/jour/article/view/153
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839572317899849728
author K. Yu. Mukhin
O. A. Pylaeva
author_facet K. Yu. Mukhin
O. A. Pylaeva
author_sort K. Yu. Mukhin
collection DOAJ
description Despite a considerable advance made in epileptology, resistant epilepsies account for approximately 30 % of all forms of epilepsy particularly in patients with focal seizures. The most common structural cause of resistant epilepsies in children is focal cortical dysplasias that are varieties of abnormal cortical development. The term “focal cortical dysplasia” was first mentioned by D. Taylor et al. in 1971 to denote local abnormalities of cortical development in our 10 described patients with resistant epilepsy. According to К. Watanabe et al. (1996), focal cortical dysplasias as a cause of epilepsy are detected in 3.0–4.3 % of patients with different forms of epilepsy. Among all abnormalities of cortical development in children who have undergone surgery for epilepsy, focal cortical dysplasias amount to 75 %, as shown by the data obtained by I. Blümcke et al. (2009).In resistant epilepsy, there is a hope for successful neurosurgical treatment and synthesis of novel antiepileptic drugs (AEDs). The authors present a review dedicated to the novel AED perampanel and consider its mechanism of action, pharmacokinetic features, indications for use, and the results of clinical trials and postmarket researches of the efficacy, tolerability, and safety of the drug, including its recent investigations. The paper describes a clinical case of successfully using perampanel in a patient with therapy-resistant epilepsy caused by focal cortical dysplasia. Based on the data available in the literature and the authors’ own cases, it тay be concluded that perampanel is a promising drug in treating epilepsy (even in epilepsies resistant to many other AEDs) with favorable indicators of tolerability.
format Article
id doaj-art-bcd51a4a2ef048bc88f878fefb53481d
institution Matheson Library
issn 2073-8803
2412-9178
language Russian
publishDate 2016-08-01
publisher ABV-press
record_format Article
series Русский журнал детской неврологии
spelling doaj-art-bcd51a4a2ef048bc88f878fefb53481d2025-08-04T14:12:11ZrusABV-pressРусский журнал детской неврологии2073-88032412-91782016-08-01112526210.17650/2073-8803-2016-11-2-52-62121USE OF PERAMPANEL IN THE TREATMENT OF EPILEPSY: A REVIEW OF LITERATURE AND A CASE REPORTK. Yu. Mukhin0O. A. Pylaeva1Svt. Luka's Institute of Child Neurology and Epilepsy, MoscowSvt. Luka's Institute of Child Neurology and Epilepsy, MoscowDespite a considerable advance made in epileptology, resistant epilepsies account for approximately 30 % of all forms of epilepsy particularly in patients with focal seizures. The most common structural cause of resistant epilepsies in children is focal cortical dysplasias that are varieties of abnormal cortical development. The term “focal cortical dysplasia” was first mentioned by D. Taylor et al. in 1971 to denote local abnormalities of cortical development in our 10 described patients with resistant epilepsy. According to К. Watanabe et al. (1996), focal cortical dysplasias as a cause of epilepsy are detected in 3.0–4.3 % of patients with different forms of epilepsy. Among all abnormalities of cortical development in children who have undergone surgery for epilepsy, focal cortical dysplasias amount to 75 %, as shown by the data obtained by I. Blümcke et al. (2009).In resistant epilepsy, there is a hope for successful neurosurgical treatment and synthesis of novel antiepileptic drugs (AEDs). The authors present a review dedicated to the novel AED perampanel and consider its mechanism of action, pharmacokinetic features, indications for use, and the results of clinical trials and postmarket researches of the efficacy, tolerability, and safety of the drug, including its recent investigations. The paper describes a clinical case of successfully using perampanel in a patient with therapy-resistant epilepsy caused by focal cortical dysplasia. Based on the data available in the literature and the authors’ own cases, it тay be concluded that perampanel is a promising drug in treating epilepsy (even in epilepsies resistant to many other AEDs) with favorable indicators of tolerability.https://rjdn.abvpress.ru/jour/article/view/153epilepsyfocal epilepsyperampanelmechanism of actionglutamatepharmacokineticsdrug interactionsdosage regimenefficacytolerabilitytherapy resistancefocal cortical dysplasia
spellingShingle K. Yu. Mukhin
O. A. Pylaeva
USE OF PERAMPANEL IN THE TREATMENT OF EPILEPSY: A REVIEW OF LITERATURE AND A CASE REPORT
Русский журнал детской неврологии
epilepsy
focal epilepsy
perampanel
mechanism of action
glutamate
pharmacokinetics
drug interactions
dosage regimen
efficacy
tolerability
therapy resistance
focal cortical dysplasia
title USE OF PERAMPANEL IN THE TREATMENT OF EPILEPSY: A REVIEW OF LITERATURE AND A CASE REPORT
title_full USE OF PERAMPANEL IN THE TREATMENT OF EPILEPSY: A REVIEW OF LITERATURE AND A CASE REPORT
title_fullStr USE OF PERAMPANEL IN THE TREATMENT OF EPILEPSY: A REVIEW OF LITERATURE AND A CASE REPORT
title_full_unstemmed USE OF PERAMPANEL IN THE TREATMENT OF EPILEPSY: A REVIEW OF LITERATURE AND A CASE REPORT
title_short USE OF PERAMPANEL IN THE TREATMENT OF EPILEPSY: A REVIEW OF LITERATURE AND A CASE REPORT
title_sort use of perampanel in the treatment of epilepsy a review of literature and a case report
topic epilepsy
focal epilepsy
perampanel
mechanism of action
glutamate
pharmacokinetics
drug interactions
dosage regimen
efficacy
tolerability
therapy resistance
focal cortical dysplasia
url https://rjdn.abvpress.ru/jour/article/view/153
work_keys_str_mv AT kyumukhin useofperampanelinthetreatmentofepilepsyareviewofliteratureandacasereport
AT oapylaeva useofperampanelinthetreatmentofepilepsyareviewofliteratureandacasereport